CXCL9 and colorectal carcinoma: Taken together, we demonstrated that SPATA2 and CYLD attenuate STAT1 accumulation and activation in CRC cells, resulting in inhibited expression of the T-cell chemokines CXCL9, CXCL10, and CXCL11 (Figure 4C).